Other KLKs have emerged as key players in PCa pathogenesis, particularly KLK2, KLK4, and KLK14, which are implicated in cancer progression through protease activity, AR modulation, and interaction with extracellular matrix components [7]. The gene discussed is KLK4; the disease is posterior cortical atrophy.